Spineguard

Spineguard R&D per Employee

The R&D Spending per Employee of Spineguard (ALSGD.PA) as of Oct 14, 2026 is 76,928.57 EUR. In the previous year, R&D Spending per Employee was 92,500.00 EUR — a change of -16.83% (lower).

R&D per Employee

76,928.57EUR

YoY

-16.83%

Last updated:

R&D Spending per Employee of Spineguard is 2025 76,928.57 EUR. R&D Spending per Employee of Spineguard was 2024 92,500.00 EUR. It decreases by -16.83% lower compared to the previous year.

The Spineguard R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
80,213.07 EUR
Jan 1, 2019
62,400.57 EUR
Jan 1, 2020
61,777.36 EUR
Jan 1, 2021
63,241.21 EUR
Jan 1, 2022
83,546.50 EUR
Jan 1, 2023
114,490.29 EUR
Jan 1, 2024
92,500.00 EUR
Jan 1, 2025
76,928.57 EUR
The Spineguard R&D per Employee history
YEARR&D per EmployeeYoY
76,928.57EUR-16.83%
92,500.00EUR-19.21%
114,490.29EUR+37.04%
83,546.50EUR+32.11%
63,241.21EUR+2.37%
61,777.36EUR-1.00%
62,400.57EUR-22.21%
80,213.07EUR-24.27%
105,920.86EUR-3.70%
109,994.36EUR+43.18%
76,822.79EUR-5.33%
81,149.86EUR—
Access this data via the Eulerpool API

Spineguard Stock analysis

What does Spineguard do? SpineGuard SA is a French company that operates in the field of medical technology. The company was founded in 2009 and is headquartered in Paris. SpineGuard is a leading provider of instruments and devices to improve the precision and effectiveness of spinal surgeries. The company focuses on developing and marketing products in the field of spinal surgery, enhancing surgical instruments and devices to assist and facilitate surgeons in performing spinal operations. SpineGuard succeeds by bringing innovative products to the market, partnering with leading orthopedic companies, and addressing customer needs. The company offers a wide range of instruments and devices for spinal surgeries, including a bone slurper, vertebral body tensioner, and pedicle shaver. It has also developed the DSG (Dynamic Surgical Guidance) technology, which provides real-time feedback to surgeons during operations, improving surgical precision and reducing the risk of complications. SpineGuard operates in three areas: instrument and device development for spinal surgery, partnerships with leading orthopedic companies, and sales and marketing. The company constantly strives to improve its products and introduce new developments to the market. In conclusion, SpineGuard is an innovative company that focuses on improving surgical instruments and devices in spinal surgery. It has established a strong presence in the medical technology market with its wide range of products and technologies. By partnering with leading orthopedic companies and utilizing a dedicated sales and marketing team, SpineGuard aims to make its products accessible to a broader audience. The company is customer-focused and continually seeks to bring innovative products to market to enhance surgical precision and effectiveness. Spineguard is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineguard stock

R&D Spending per Employee of Spineguard is 76,928.57 EUR in 2025.

R&D Spending per Employee of Spineguard changed from 92,500.00 EUR to 76,928.57 EUR, representing a -16.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Spineguard since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Spineguard historically and in real time.

Access this data via the Eulerpool API

Workforce — Spineguard

All Key Metrics — Spineguard